Addiction and pain medicine.

Area of Science:

• Pharmacology and Addiction Medicine
• Pain Management and Cannabinoid Therapeutics

Background:

• Chronic pain and addiction disorders require complex cotreatment strategies.
• Cannabinoids offer potential for pain relief but face challenges due to rising recreational cannabis use and associated cannabis use disorders.
• Concerns exist regarding the abuse liability of cannabinoids, particularly for individuals with a history of substance abuse.

Purpose of the Study:

• To explore the challenges and considerations in using cannabinoids for pain management in patients with or at risk of addiction disorders.
• To highlight the need for pharmaceutical-grade cannabinoid products and safer delivery systems.
• To address issues related to differentiating prescribed from illicit cannabinoids in drug testing.

Main Methods:

• Review of existing evidence on cannabinoid efficacy for pain.
• Analysis of data concerning cannabis use disorder prevalence and risk factors.
• Consideration of different cannabinoid administration methods and their associated risks.
• Evaluation of challenges in clinical practice, including drug testing.

Main Results:

• Cannabis use disorder liability may be higher than previously assumed.
• Smoked cannabis demonstrates higher reinforcing properties and is linked to adverse health outcomes compared to other administration methods.
• Difficulty in distinguishing medicinal from illicit cannabinoids in urine drug tests complicates clinical management.

Conclusions:

• A comprehensive risk-benefit assessment of cannabinoids is essential, considering individual patient history of substance abuse.
• Development of pharmaceutical-grade cannabinoids with safe delivery systems is needed.
• Further research is required to optimize the safe and effective use of cannabinoids in pain management for at-risk populations.